Revolution Medicines RVMD
NASDAQ RVMD
$177.96 -11.30 (-5.97%)
At close: Oct 16, 2026 · 4:00 PM EDT

Revolution Medicines (RVMD) Gains from Sales and Divestitures (2019 - 2025)

Updated

Revolution Medicines (RVMD) reported Gains from Sales and Divestitures of -$32,000 for FY2025, compared with -$118,000 in FY2024.

Analysis

Revolution Medicines (RVMD) Gains from Sales and Divestitures (2019 - 2025) Analysis & Trends

Dating back to FY2018, Revolution Medicines' Gains from Sales and Divestitures record includes 7 years.

  • The FY2025 figure ranks as the highest annual Gains from Sales and Divestitures since FY2022.
  • According to Business Quant data, Gains from Sales and Divestitures came in at -$118,000 in FY2024, -$52,000 in FY2023, -$19,000 in FY2022 and -$119,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Revolution Medicines 37.70 Bn 27.90 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -32,000.00
Dec 31, 2024 200,000.00
Sep 30, 2024 -202,000.00
Jun 30, 2024 -43,000.00
Mar 31, 2024 -73,000.00
Dec 31, 2023 -51,000.00
Mar 31, 2023 -1,000.00
Mar 31, 2022 -19,000.00
Dec 31, 2021 -15,000.00
Sep 30, 2021 -104,000.00
Dec 31, 2019 -176,000.00
Sep 30, 2019 5,000.00
Jun 30, 2019 -59,000.00
Mar 31, 2019 4,000.00
API Access

Revolution Medicines Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=RVMD&period=max&api_key=YOUR_API_KEY